NCT03547804View on ClinicalTrials.gov

A Prospective, Single-center, One-arm Clinical Study of Apatinib Combined With Chemotherapy for Pretreated Patients With Advanced Small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

May 31, 2018

Primary Completion Date

October 25, 2019

Study Completion Date

September 1, 2020

Conditions
Small-cell Lung Cancer
Interventions
DRUG

Apatinib

500 mg qd/250mg

DRUG

chemotherapy

Chemotherapeutic agents are limited to irinotecan or docetaxel alone.

Trial Locations (1)

130000

The First Hospital Of Jilin University, Changchun

All Listed Sponsors
lead

The First Hospital of Jilin University

OTHER

NCT03547804 - A Prospective, Single-center, One-arm Clinical Study of Apatinib Combined With Chemotherapy for Pretreated Patients With Advanced Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter